Navigation Links
Clarient to Commercialize Novel Breast Cancer Profile
Date:1/9/2008

t our strong cancer-focused brand, support and loyalty among community pathologists and our unique, Internet-based PATHSiTE(TM) delivery system will drive market acceptance for this exciting test."

The new breast cancer profile has undergone rigorous validation. The results to date show excellent accuracy and substantial out-performance of standard treatment guidelines. As preparations are made for full market launch in 2008, the companies will continue to generate clinical data designed to further expand the established indications and to comply with future regulatory requirements. The companies believe that Clarient's Insight Dx Breast Cancer Profile fits the description of a lab-developed test according to the current regulatory guidelines. Should the FDA adopt proposed guidance to regulate certain lab-developed tests, the companies intend to submit the required documentation for clearance within the timeframe provided.

"Clarient currently performs approximately 20 percent of all breast cancer prognostic work-ups in the U.S.," Andrews continued. "We are extremely proud of the brand we have developed in such a short period in the area of breast cancer, and the availability of this high-value test could improve patient care and decrease the economic burden on the healthcare system."

About Prediction Sciences

Based in La Jolla, California, Prediction Sciences develops high-value molecular diagnostics and assays for disease detection, prognosis, and treatment outcome prediction under their trademarked brand names, RapidResponse(TM) and GeneRx(TM). Prediction Sciences has a deep diagnostics pipeline, with lead candidates that address critical unmet clinical needs in oncology and stroke. Prediction Sciences is committed to improving the safety and efficacy of disease treatments, and their diagnostic tests are making personalized medicine a reality. http://www.predict.net

About Clarien
'/>"/>

SOURCE Clarient
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
2. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
3. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
4. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
5. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
6. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
7. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
8. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
9. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
10. First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD
11. DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... Executive Officer of Regulus, will present a company overview ... Healthcare Conference on Wednesday, March 4, 2015 at 9:20 ... Boston Marriott Copley Place.  The presentation ...
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... 2015 The Pittcon 2015 Exposition, ... Ernest N. Morial Convention Center in New Orleans, ... February 19, 2015) displaying products and services used ... government labs. The Exposition will offer the latest ... to, analytical chemistry; drug discovery; nanotechnology; life sciences ...
(Date:2/26/2015)... According to a new market report published by ... (Corn, Soybean, Cotton and Others), Synthetic Biology-Enabled Products and ... and Forecast, 2013 – 2019,”the global agricultural biotechnology market ... is expected to reach USD 28,694.1 million by 2019, ... 2019. , Demand for food production has increased ...
Breaking Biology Technology:Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Pittcon 2015 Announces Exposition Highlights 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3
... Favrille, Inc. (Nasdaq:,FVRL) today announced that it ... 2008 indicating that, for the last 30 consecutive ... common stock has been below,the minimum $1.00 per ... $5,000,000 minimum market value of publicly held shares ...
... the ... Treatment of Stuttering, ROANOKE, Va., ... non-profit research and,clinical center ( http://www.stuttering.org ) specializing ... stuttering,therapy with advanced behavioral, electronic and computer technologies that,significantly improve ...
... for Aging Services Technologies, (CAST) to Expedite Emerging ... 15 Samarion CEO Mark Rodgers was,recently named ... to help lead the charge to expedite emerging ... an international coalition ensuring that technology solutions,attain their ...
Cached Biology Technology:Favrille Announces Receipt of Nasdaq Letters 2Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech 2Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech 3Samarion CEO Mark Rodgers Named CAST Commissioner 2
(Date:2/18/2015)... Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... speaking at the following conferences, and invited investors to participate ... Boston, MA Tuesday, March 3, 2015 ... Investors Conference, Orlando, FL Wednesday, March ... Live Webcasts To access the live webcasts for these events, ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... HAIFA, Israel , April 27, 2010 Oil Refineries,Ltd. (TASE: ... its Annual & Special General,Meeting scheduled for Monday, April 26, 2010 to Monday, ... remains the same. , , , ... , , ...
... , April 27, 2010 Cellcom Israel,Ltd. (NYSE: ... of a purported,class action lawsuit filed in March 2009 ... by a plaintiff alleging to be the Company,s,subscriber, in connection ... The purported class action was dismissed,without prejudice, following the request ...
... Tuesday morning between Temple University Hospital (TUH) and the Pennsylvania Association of ... resume later today at 1:00 p.m. , ... Continued progress was reported, but the parties remain apart on economics. , ... Temple University Hospital is committed to meet with the ...
Cached Biology News:Oil Refineries Announces Delay to Annual & Special General Meeting 2Cellcom Israel Ltd. Announces Dismissal of a Purported Class Action 2
... 2-3x faster than western blotting. Get results ... Direct on gel detection. Eliminates the need ... detection methods. All reagents are ready-to-use. No ... to use. Only 2 reagents required. Guarantees a ...
... The EZ-Tn5™ Plasmid-Based Deletion Machine is ... vitro transposition system developed by Goryshin and ... generation of nested families of deletions and ... cloned in a transposon-containing plasmid vector. Although ...
... This kit is designed to knockout or alter ... less than one week. Red/ET recombination allows the ... precise, specific, and faithful manner. An FRT-flanked kanamycin ... which can be used to replace a gene ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Biology Products: